Home »
THURSDAY, Feb. 13, 2020 — Ketamine use among electronic dance music party-goers is much higher than previously thought. And unintentional use appears to play a role, a new study finds. Ketamine is known as Special K on the party scene. The operating room anesthetic was approved by the U.S. Food and Drug Administration in 2019 as a treatment for depression. […]
Read more
In a UCLA-led phase I clinical trial, a new plant-based drug called APG-157 showed signs of helping patients fight oral and oropharyngeal cancers. These cancers are located in the head and the neck. APG-157 is made up of multiple compounds produced by plants, including curcumin. UCLA Jonsson Comprehensive Cancer Center researchers found that treatment with this botanical drug resulted in […]
Read more
Media reports on chronic pain are focusing on treatments involving opioids and cannabis at the expense of best practice non-drug treatments, researchers have found. Chronic pain, defined as persistent or recurring pain present for more than three months, is the leading cause of disability worldwide and affects one in five New Zealanders. The researchers analyzed 240 news articles on chronic […]
Read more
Credit: Michael S. Helfenbein University researchers finds that scaling up use of methadone and buprenorphine—medications for treating opioid use disorder known as opioid agonist therapies (OATs)—could greatly reduce HIV transmission rates and prevent deaths in Ukraine, where the disease is epidemic among people who inject drugs. The study was published in The Lancet. Annual new HIV infections in Ukraine—home to […]
Read more
Controversial weight loss drug pulled from sale in the 1990s over heart damage fears ‘cuts the number of seizures in children with a severe form of epilepsy’ Fenfluramine was found to make people develop leaky heart valves in high doses Doctors stopped using it in 1997 but it has been found to have brain benefits It could reduce seizures by […]
Read more
Tumor volume in a preclinical model of triple negative breast cancer (TNBC) was reduced four times more when an experimental polo-like kinase 1 (PLK1) inhibitor was combined with a standard-of-care chemotherapeutic agent than when the agent was used alone. Hollings Cancer Center scientists at the Medical University of South Carolina reported these findings in PLOS ONE. TNBC disproportionately affects African […]
Read more
A groundbreaking clinical approach has been developed combining new diagnostic techniques to detect a leaking blood-brain barrier (BBB) with a new anti-inflammatory drug that for the first time slows or reverses age-related cognitive decline. In two related studies published in the journal Science Translational Medicine, researchers from Ben-Gurion University of the Negev (BGU) and the University of California, Berkeley (UC) […]
Read more
Scientists at Sanford Burnham Prebys Medical Discovery Institute have identified a combination of two anti-cancer compounds that shrank pancreatic tumors in mice—supporting the immediate evaluation of the drugs in a clinical trial. U.S. Food and Drug Administration (FDA)-approved versions of the compounds are used today to treat certain leukemias and solid tumors, including melanoma. The study was published in Nature […]
Read more
Machine learning’s powerful ability to detect patterns in complex data is revolutionizing how we drive, how we diagnose disease and now, how we discover new drugs. Scientists at Sanford Burnham Prebys Medical Discovery Institute have developed a machine-learning algorithm that gleans information from microscope images—allowing for high-throughput epigenetic drug screens that could unlock new treatments for cancer, heart disease, mental […]
Read more
The underdeveloped lungs and immune systems of premature babies put them at high risk of potentially deadly pneumonia. Now, a study from Washington University School of Medicine in St. Louis has found, in mice, that an inhaled drug promotes the development of lung immunity and reduces the risk of pneumonia. The findings, published Aug. 14 in Science Advances, suggest that […]
Read more